title: [Postoperative refractory chylothorax which was improved by octreotide acetate].
abstract: A 77-year-old male with chronic hepatitis and liver cirrhosis underwent a right middle-lower lobectomy and lymph node dissection because of non-small cell carcinoma of the lung. On the 1st post-operative day (POD1), a large quantity of chylous pleural effusion was recognized after he initiated oral intake. The diagnosis was postoperative chylothorax. Conservative therapy including a medium chain tryglyceride diet and total parental nutrition were not effective. Considering of the patient's past history, we decided to continue conservative therapy using octreotide acetate on POD7. After administration of the octreotide acetate, the volume of chylous pleural effusion gradually decreased. The chest tube was removed on POD19. Octeotide acetate should be a choice for the conservative treatment of postoperative refractory chylothorax.
authors.affiliation: Department of Surgery, Okinawa Prefectual Hokubu Hospital, Nago, Japan.
authors.forename: Atsushi
authors.initials: A
authors.lastname: Gabe
authors.forename: Masahiro
authors.initials: M
authors.lastname: Seki
authors.forename: Naohiro
authors.initials: N
authors.lastname: Taira
authors.forename: Morihiro
authors.initials: M
authors.lastname: Katsura
authors.forename: Tomoki
authors.initials: T
authors.lastname: Ishida
authors.forename: Yukijya
authors.initials: Y
authors.lastname: Kang
authors.forename: Tadao
authors.initials: T
authors.lastname: Kubota
authors.forename: Toshimitsu
authors.initials: T
authors.lastname: Yamashiro
authors.forename: Tetsuo
authors.initials: T
authors.lastname: Uehara
authors.forename: Tohru
authors.initials: T
authors.lastname: Sunagawa
authors.forename: Kazuaki
authors.initials: K
authors.lastname: Ohkubo
mesh_terms: D000368:Aged; D002916:Chylothorax / Q000188:drug therapy* / Q000209:etiology; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000601:surgery; D008297:Male; D015282:Octreotide / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000188:drug therapy*
chemical_list: D005765:Gastrointestinal Agents; D015282:Octreotide